Statistics for REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal
Total visits
| views | |
|---|---|
| REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal | 419 |
Total visits per month
| views | |
|---|---|
| November 2024 | 2 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| Neurol Sci 2020.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| Ukraine | 133 |
| Germany | 79 |
| United States | 65 |
| China | 39 |
| Israel | 37 |
| Portugal | 16 |
| Sweden | 11 |
| Australia | 8 |
| Canada | 6 |
| Latvia | 3 |
| Mongolia | 2 |
| Vietnam | 2 |
| Unknown Region | 2 |
| Argentina | 1 |
| Brazil | 1 |
| Czechia | 1 |
| France | 1 |
| United Kingdom | 1 |
| Greece | 1 |
| India | 1 |
| Netherlands | 1 |
| New Zealand | 1 |
| Pakistan | 1 |
| Russia | 1 |
| Thailand | 1 |